Literature DB >> 18784103

Gonadotropin-releasing hormone agonists for endometriosis.

David L Olive1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18784103     DOI： 10.1056/NEJMct0803719

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Fertility considerations in young women with hematological malignancies.

Authors:  Pascale Jadoul; S Samuel Kim
Journal:  J Assist Reprod Genet       Date:  2012-05-22       Impact factor: 3.412

2.  Oral continuous combined 0.5 mg estradiol valerate and 5 mg dydrogesterone as daily add-back therapy during post-operative GnRH agonist treatment for endometriosis in Chinese women.

Authors:  Shien Zou; Qiqi Long; Shaofen Zhang; Yi Han; Wei Zhang
Journal:  Int J Clin Exp Med       Date:  2012-11-30

3.  Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insufficiency in female mice treated with alkylating chemotherapy.

Authors:  Malgorzata E Skaznik-Wikiel; Megan M McGuire; Meena Sukhwani; Julia Donohue; Tianjiao Chu; Thomas C Krivak; Aleksandar Rajkovic; Kyle E Orwig
Journal:  Fertil Steril       Date:  2013-02-26       Impact factor: 7.329

4.  Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms.

Authors:  Sakhila K Banu; JeHoon Lee; V O Speights; Anna Starzinski-Powitz; Joe A Arosh
Journal:  Mol Endocrinol       Date:  2009-04-30

5.  Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density.

Authors:  Bruce Carr; W Paul Dmowski; Chris O'Brien; Ping Jiang; Joshua Burke; Roland Jimenez; Elizabeth Garner; Kristof Chwalisz
Journal:  Reprod Sci       Date:  2014-09-23       Impact factor: 3.060

Review 6.  Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT.

Authors:  Michael von Wolff; Markus Montag; Ralf Dittrich; Dominik Denschlag; Frank Nawroth; Barbara Lawrenz
Journal:  Arch Gynecol Obstet       Date:  2011-03-24       Impact factor: 2.344

7.  Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study.

Authors:  Bruce Carr; Linda Giudice; W Paul Dmowski; Chris O'Brien; Ping Jiang; Joshua Burke; Roland Jimenez; Steven Hass; Mahesh Fuldeore; Kristof Chwalisz
Journal:  J Endometr Pelvic Pain Disord       Date:  2013-07-13

8.  Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study.

Authors:  Thomas D'Hooghe; Takao Fukaya; Yutaka Osuga; Robin Besuyen; Beatriz López; Gertjan M Holtkamp; Kentaro Miyazaki; Laurence Skillern
Journal:  Hum Reprod       Date:  2019-05-01       Impact factor: 6.918

9.  Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial.

Authors:  Xiaoyan Li; Huaifang Li; Hong Shi; Xiaomao Li; Renfeng Zhou; Dan Lu; Yunlang Cai; Yingfang Zhou; Patrick Cabri; Xiaofeng Shi; Anna Pedret-Dunn; Jinhua Leng
Journal:  Adv Ther       Date:  2022-08-10       Impact factor: 4.070
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.